Drug
Celecoxib
Celecoxib: highest development phase Post-Market, developed by Pfizer. 4 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Celecoxib NCT00643799 | Post-Market | Osteoarthritis, Knee |
| Celecoxib NCT00137033 | Post-Market | Peptic Ulcers |
| celecoxib NCT00484718 | Post-Market | Osteoarthritis |
| Celecoxib NCT00585312 | Phase 3 | Adenomatous Polyposis Coli |
Latest
No recent events.
Follow Celecoxib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.